TA
TLS Advisors Portfolio holdings
AUM
$32M
This Quarter Return
-17.91%
1 Year Return
+15.09%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$20.3M
AUM Growth
–
Cap. Flow
+$20.3M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
90.13%
Holding
21
New
21
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
EQT Corp
EQT
|
$5.1M |
| 2 |
Ovid Therapeutics
OVID
|
$2.77M |
| 3 |
Xoma
XOMA
|
$2.28M |
| 4 |
Meta Platforms (Facebook)
META
|
$1.76M |
| 5 |
OmniAb
OABI
|
$1.39M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 50.2% |
| 2 | Energy | 25.89% |
| 3 | Communication Services | 10.32% |
| 4 | Financials | 6.84% |
| 5 | Consumer Discretionary | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
EQT Corp
EQT
$32.4B
| $5.1M | 25.15% | +150,800 | New | +$5.1M |
|
|
2
Ovid Therapeutics
OVID
$91M
| $2.77M | 13.66% | +1,490,534 | New | +$2.77M |
|
|
3
Xoma
XOMA
$392M
| $2.28M | 11.25% | +124,024 | New | +$2.28M |
|
|
4
Meta Platforms (Facebook)
META
$1.86T
| $1.76M | 8.65% | +14,589 | New | +$1.76M |
|
|
5
OmniAb
OABI
$230M
| $1.39M | 6.86% | +386,592 | New | +$1.39M |
|
|
SI
6
DELISTED
Silvergate Capital Corporation
SI
| $1.39M | 6.84% | +79,795 | New | +$1.39M |
|
7
Xenon Pharmaceuticals
XENE
$2.98B
| $1.33M | 6.56% | +33,756 | New | +$1.33M |
|
|
BLU
8
DELISTED
BELLUS Health Inc.
BLU
| $1.03M | 5.1% | +125,731 | New | +$1.03M |
|
9
Tesla
TSLA
$1.08T
| $739K | 3.64% | +6,000 | New | +$739K |
|
10
MEI Pharma
MEIP
$160M
| $490K | 2.42% | +2,010,285 | New | +$490K |
|
|
FSTX
11
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $343K | 1.69% | +54,298 | New | +$343K |
|
|
NBIS
12
Nebius Group N.V. Class A Ordinary Shares
NBIS
$16.3B
| $337K | 1.66% | +17,811 | New | +$337K |
|
13
Hovnanian Enterprises
HOV
$827M
| $272K | 1.34% | +6,472 | New | +$272K |
|
14
iShares MSCI Singapore ETF
EWS
$792M
| $255K | 1.26% | +13,600 | New | +$255K |
|
|
AFMD
15
DELISTED
Affimed
AFMD
| $201K | 0.99% | +161,971 | New | +$201K |
|
16
Regeneron Pharmaceuticals
REGN
$61.5B
| $180K | 0.89% | +250 | New | +$180K |
|
17
Nkarta
NKTX
$151M
| $161K | 0.79% | +26,842 | New | +$161K |
|
18
Range Resources
RRC
$8.16B
| $150K | 0.74% | +59,823 | New | +$150K |
|
|
APTO
19
DELISTED
Aptose Biosciences, Inc.
APTO
| $52K | 0.26% | +89,403 | New | +$52K |
|
|
NNDM
20
Nano Dimension
NNDM
$300M
| $51K | 0.25% | +22,000 | New | +$51K |
|
|
NIRWW
21
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
| $1K | ﹤0.01% | +10,000 | New | +$1K |
|